NASDAQ:NEPT - Neptune Wellness Solutions Stock Price, Forecast & News

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Neptune Wellness Solutions Inc (NASDAQ:NEPT) released its quarterly earnings results on Wednesday, October, 12th. The biotechnology company reported ($0.02) earnings per share for the quarter. The biotechnology company had revenue of $8.91 million for the quarter. Neptune Wellness Solutions had a negative net margin of 132.09% and a negative return on equity of 39.22%. View Neptune Wellness Solutions' Earnings History.

Neptune Wellness Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, June 10th 2020. View Earnings Estimates for Neptune Wellness Solutions.

3 brokerages have issued 12 month price objectives for Neptune Wellness Solutions' shares. Their forecasts range from $3.75 to $3.75. On average, they expect Neptune Wellness Solutions' stock price to reach $3.75 in the next twelve months. This suggests a possible upside of 86.6% from the stock's current price. View Analyst Price Targets for Neptune Wellness Solutions.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neptune Wellness Solutions.

Headlines about NEPT stock have trended extremely negative recently, InfoTrie reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Neptune Wellness Solutions earned a coverage optimism score of -4.4 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Neptune Wellness Solutions.

Some companies that are related to Neptune Wellness Solutions include Portola Pharmaceuticals (PTLA), CannTrust (CNTTF), Collegium Pharmaceutical (COLL), Aprea Therapeutics (APRE), DiaMedica Therapeutics (DMCAF), Phoenix Tree (IMAB), Homology Medicines (FIXX), Frequency Therapeutics (FREQ), ANI Pharmaceuticals (ANIP), Arcus Biosciences (RCUS), G1 Therapeutics (GTHX), ImmunoGen (IMGN), Vectura Group (VEGPF), Eagle Pharmaceuticals (EGRX) and Basilea Pharmaceutica (BPMUF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Tilray (TLRY), Zynerba Pharmaceuticals (ZYNE), Amarin (AMRN), Aphria (APHA), Cara Therapeutics (CARA), Acasti Pharma (ACST) and New Age Beverages (NBEV).

Neptune Wellness Solutions' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include AdvisorShares Investments LLC (0.38%), Essex Investment Management Co. LLC (0.26%), Renaissance Technologies LLC (0.20%), Oxford Asset Management LLP (0.11%), Penserra Capital Management LLC (0.07%) and Cambria Investment Management L.P. (0.06%).

NEPT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Cubist Systematic Strategies LLC.

NEPT stock was purchased by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, Essex Investment Management Co. LLC, Oxford Asset Management LLP, Cambria Investment Management L.P., TD Asset Management Inc., Virtu Financial LLC, Credit Suisse AG and Penserra Capital Management LLC.

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NEPT stock can currently be purchased for approximately $2.01.

Neptune Wellness Solutions has a market capitalization of $190.73 million and generates $18.39 million in revenue each year. The biotechnology company earns $-17,670,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.View Additional Information About Neptune Wellness Solutions.

The official website for Neptune Wellness Solutions is http://www.neptunecorp.com/.

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]